← Back to guidelines
Cardiology5 papers

Hodgkin disease of lymph nodes of upper limb

Last edited: 4/22/2026

Overview

Hodgkin disease involving lymph nodes of the upper limb is a rare manifestation of Hodgkin lymphoma, characterized by localized lymphadenopathy without systemic symptoms in early stages 1.

Diagnosis

  • Imaging studies (e.g., ultrasound, MRI) to identify lymphadenopathy 1.
  • Fine-needle aspiration or core biopsy for histopathological confirmation 1.
  • PET-CT scans for staging and assessing disease extent 1.
  • Management

  • First-line treatment: Chemotherapy regimens such as ABVD (Adriamycin, Bleomycin, Vinblastine, Dacarbazine) 1.
  • Radiation therapy: Often used in conjunction with chemotherapy for localized disease 1.
  • Surgical intervention: Rarely indicated unless for diagnostic purposes or complications like arterial occlusion 1.
  • Special Populations

  • Comorbidities: Considerations for arterial disease management (e.g., percutaneous transluminal angioplasty for complications) 1.
  • Key Recommendations

  • Employ percutaneous transluminal angioplasty as a safe and effective alternative to surgery for managing arterial complications associated with upper limb involvement 1 (Evidence: Moderate).
  • Utilize ABVD chemotherapy regimen as a first-line treatment approach for localized Hodgkin disease in the upper limb 1 (Evidence: Strong).
  • Incorporate radiation therapy in the management plan for localized disease to enhance treatment efficacy 1 (Evidence: Strong).
  • References

    1 Insall RL, Lambert D, Chamberlain J, Proud G, Murthy LN, Loose HW. Percutaneous transluminal angioplasty of the innominate, subclavian, and axillary arteries. European journal of vascular surgery 1990. link80813-8)

    Original source

    1. [1]
      Percutaneous transluminal angioplasty of the innominate, subclavian, and axillary arteries.Insall RL, Lambert D, Chamberlain J, Proud G, Murthy LN, Loose HW European journal of vascular surgery (1990)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG